These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3322971)

  • 1. [Oral, slow release morphine for chronic pain].
    Lishner M; Ravid M
    Harefuah; 1987 Jun; 112(12):615-7. PubMed ID: 3322971
    [No Abstract]   [Full Text] [Related]  

  • 2. Pain corner. Sustained-release opioid preparations.
    Michaud M
    AARN News Lett; 1992 Dec; 48(11):17. PubMed ID: 1481620
    [No Abstract]   [Full Text] [Related]  

  • 3. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphine for cancer pain.
    Glavina MJ
    N Z Med J; 1991 Jan; 104(904):6-7. PubMed ID: 2008261
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged release extradural morphine.
    Howard EC; Murray GR; Calvey TN; Williams NE
    Ann R Coll Surg Engl; 1985 Jan; 67(1):8-10. PubMed ID: 3966787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain.
    Panich A; Charnvej L
    J Med Assoc Thai; 1993 Dec; 76(12):672-6. PubMed ID: 7798818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid formulations: tailoring to the needs in chronic pain.
    Reder RF
    Eur J Pain; 2001; 5 Suppl A():109-11. PubMed ID: 11798229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retard morphine for oral pain therapy. Once daily administration as basic opioid--experiences with 2,840 patients].
    Dierke-Dzierzon C; Beau I; Lindena G; Sturm M
    Fortschr Med; 1998 Apr; 116(12):45-6. PubMed ID: 9622976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].
    Schulzeck S; Gleim M; Maier C
    Anaesthesist; 1993 Aug; 42(8):545-56. PubMed ID: 8368476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine: immediate release vs. controlled release.
    Homesley HD
    N C Med J; 1989 Jul; 50(7):390-4. PubMed ID: 2755518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing pain with long-acting morphine.
    Ferrell BR
    Nursing; 1991 Oct; 21(10):34-40. PubMed ID: 1923023
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach to cancer pain management.
    Black DJ
    J Fam Pract; 1989 Mar; 28(3):267-8. PubMed ID: 2926341
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for routine use of controlled-release oral morphine sulfate tablets.
    Warfield CA
    Semin Oncol; 1993 Apr; 20(2 Suppl 1):36-47. PubMed ID: 7682729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
    Nicholson B; Ross E; Weil A; Sasaki J; Sacks G
    Curr Med Res Opin; 2006 Mar; 22(3):539-50. PubMed ID: 16574037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of Kadian (morphine sulfate sustained-release capsules) in patients with chronic, nonmalignant pain.
    Chao J
    Pain Med; 2005; 6(3):262-5. PubMed ID: 15972090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
    Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
    Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, multiple dose, open label study of the initiation of sustained-release morphine sulfate (SRMS) in chronic pain.
    Ritch P; Plezia P; Rushing D; Heilman R; Finn J; Andresen S; Schobelock M; Mosdell K; Shepard K
    Am J Hosp Palliat Care; 1995; 12(4):18-23. PubMed ID: 7632488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.